Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present BioPharmX Corporation (OTC: BPMX).

Full DD Report for BPMX

Recent News from (OTC: BPMX)

Today's Research Reports on Trending Tickers: BioPharmX and MediWound
NEW YORK, NY / ACCESSWIRE / March 21, 2018 / Stock markets rallied Tuesday on gains from the energy and consumer discretionary sector. Wall Street appears to be eagerly awaiting details from the Federal Reserve's upcoming policy meeting. As per CME Group's FedWatch tool, as of Tuesday, mark...
Source: ACCESSWIRE IA
Date: March, 21 2018 08:00
BioPharmX Cancels Presentation at Oppenheimer's 28th Annual Healthcare Conference Due to Severe Weather
MENLO PARK, Calif. , March 20, 2018 /PRNewswire/ -- BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company developing dermatology products, today announces that it has cancelled its presentation at Oppenheimer's 28 th Annual Healthcare Conference in New Yor...
Source: PR Newswire
Date: March, 20 2018 20:30
U.S. Patent and Trademark Office Awards BioPharmX Patent Protection for Novel Tetracycline-class Topical Drug Compositions
MENLO PARK, Calif. , March 20, 2018 /PRNewswire/ -- BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company developing products for the dermatology market, today announced the U.S. Patent and Trademark Office has granted the first in what the company expects w...
Source: PR Newswire
Date: March, 20 2018 09:15
Key events next week - healthcare (continued #1)
Tuesday (3/20): Oppenheimer (continued). BioLineRx (NASDAQ: BLRX ); Aerie Pharmaceuticals (NASDAQ: AERI ); United Therapeutics (NASDAQ: UTHR ); Addus HomeCare (NASDAQ: ADUS ); Centene (NYSE: CNC ); Quorum Health (NYSE: QHC ); Pfenex (NYSEMKT: PFNX ); SELLAS Life Sciences (NASDAQ: SLS...
Source: SeekingAlpha
Date: March, 16 2018 10:26
BioPharmX to Present at Oppenheimer's 28th Annual Healthcare Conference
MENLO PARK, Calif. , March 14, 2018 /PRNewswire/ -- BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company developing dermatology products, today announces that it will present its updated corporate presentation at Oppenheimer's 28 th Annual Healthcare Confe...
Source: PR Newswire
Date: March, 14 2018 09:15
BioPharmX to Present at 30th Annual ROTH Conference
MENLO PARK, Calif. , March 5, 2018 /PRNewswire/ -- BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company developing dermatology products, today announces that it will present its updated corporate presentation at the 30 th Annual ROTH Conference in Orange Count...
Source: PR Newswire
Date: March, 05 2018 09:15
Investor Expectations to Drive Momentum within Graphic Packaging Holding, Invitation Home, Teradyne, Dean Foods, Valley National, and BioPharmX - Discovering Underlying Factors of Influence
NEW YORK, Feb. 07, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Graphic Packaging Holding Company (NYSE:GPK), Invitation Home Inc. (NYSE:...
Source: GlobeNewswire
Date: February, 07 2018 08:15
BioPharmX To Present Data On New Fluorescence Lifetime Imaging Microscopy to Measure How Effectively Topically Applied Minocycline Reaches Targets in Skin
MENLO PARK, Calif. , Jan. 26, 2018 /PRNewswire/ -- BioPharmX Corporation (NYSE American: BPMX), a specialty pharmaceutical company developing dermatology products, today announced that a revolutionary technique to measure how effectively a single dose of topically applied minocycline...
Source: PR Newswire
Date: January, 26 2018 09:15
BioPharmX To Present BPX-04 Rosacea Data At Two Leading Clinical Conferences This Month
MENLO PARK, Calif. , Jan. 12, 2018 /PRNewswire/ -- BioPharmX Corporation (NYSE MKT: BPMX), a specialty pharmaceutical company developing products for the dermatology market, will present to the medical community preliminary data from the treatment of rosacea using its novel topical g...
Source: PR Newswire
Date: January, 12 2018 09:15
Free Post Earnings Research Report: BioPharmX's Adjusted EPS Beat Expectations
LONDON, UK / ACCESSWIRE / January 09, 2018 / Active-Investors.com has just released a free earnings report on BioPharmX Corp. (NYSE: BPMX ). If you want access to this report all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=B...
Source: ACCESSWIRE IA
Date: January, 09 2018 07:40

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-04-230.22260.2170.2250.2122,724,632
2018-04-220.22850.22260.23420.2223,057,071
2018-04-210.22850.22260.23420.2223,057,071
2018-04-200.22850.22260.23420.2223,057,071
2018-04-190.24010.22780.2450.2254,896,252

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator

Short Analysis provided by Squeeze Report.


About BioPharmX Corporation (OTC: BPMX)

Logo for BioPharmX Corporation (OTC: BPMX)

BioPharmX, Inc. provides innovative drug delivery products through its unique, patented platform technologies for pharmaceutical and OTC applications.

 

Contact Information

 

 

Current Management

  • James Pekarsky / CEO, CFO, Treasurer
  • Anja Krammer / President, Secretary
  • Stephen Morlock / Director, Business Control
  • Kin Foong Chan / Research amp Development
  • James Pekarsky / Chairman
  • Michael Hubbard /
  • Anja Krammer /

Current Share Structure

  • Market Cap: $3,746,409 - 03/20/2018
  • Authorized: 100,000,000 - 02/28/2018
  • Issue and Outstanding: 12,026,994 - 02/28/2018

 


Recent Filings from (OTC: BPMX)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 13 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 09 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 14 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 12 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: January, 16 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: January, 16 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: December, 12 2017
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: December, 07 2017
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: December, 01 2017
Statement of beneficial ownership of common stock by certain persons
Filing Type: SC 13GFiling Source: edgar
Filing Date: November, 30 2017

 

 


Daily Technical Chart for (OTC: BPMX)

Daily Technical Chart for (OTC: BPMX)


Stay tuned for daily updates and more on (OTC: BPMX)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: BPMX)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

Monsta Trader
@MonstaTrader

 

 


Disclaimer: Monsta Trader publishes reports providing information on selected companies. Monsta Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. Monsta Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in BPMX is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Monsta Trader has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. Monsta Trader does not own any shares of BPMX and does not buy, sell, or trade any shares of BPMX. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2016 by Monsta Trader. All rights reserved. Our Full Disclaimer: http://monstatrader.com/disclaimer/

 

 

Release this Report to Investors

Via Email

Via Text

Important

If you would like to schedule the release please Contact Us and we will assist you otherwise we will release this report to investors 15 minutes after payment is received to allow the most current information to be updated before the report is sent. Interested in reaching more investors? Contact Us